🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Iowa › Cedar Rapids

Acute Myeloid Leukemia clinical trials in Cedar Rapids, IA

16 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Ages 18 to 59 · All sexes · Updated Sep 28, 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecruitingPhase 1/2
  • University of Iowa Hospital, Iowa City · 25 mi away
30 Days · All sexes · Updated Sep 16, 2026 · NCT04065399

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Mercy Hospital, Cedar Rapids
  • Oncology Associates at Mercy Medical Center, Cedar Rapids
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

RecruitingObservational study
  • University of Iowa Hospital and Clinics, Iowa City · 25 mi away
Ages 0 and older · All sexes · Updated Sep 2, 2026 · NCT07154823

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

RecruitingPhase 1
  • University of Iowa Health Care, Iowa City · 25 mi away
Ages 18 to 75 · All sexes · Updated Aug 31, 2026 · NCT07177079

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecruitingPhase 3
  • University of Iowa Stead Family Children's Hospital, Iowa City · 25 mi away
29 Days – 21 Years · All sexes · Updated Aug 24, 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
  • University of Iowa, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RecruitingPhase 3
  • University of Iowa Hospitals and Clinics, Iowa City · 25 mi away
Ages 18 to 75 · All sexes · Updated Jul 17, 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • University of Iowa, Iowa City · 25 mi away
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • University of Iowa Hospitals & Clinics, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Cedar Rapids

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.